- $1.56bn
- $1.68bn
- $935.10m
- 95
- 43
- 96
- 92
2019 March 31st | 2020 March 29th | 2021 March 28th | 2022 April 3rd | 2023 April 2nd | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 52 W | 53 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 556 | 540 | 597 | 775 | 935 |
Cost of Revenue | |||||
Gross Profit | 95.9 | 101 | 124 | 147 | 165 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 520 | 499 | 541 | 703 | 847 |
Operating Profit | 36.8 | 41.7 | 55.9 | 71.2 | 88.2 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 33.5 | 39 | 55.9 | 70 | 82.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 24.4 | 28.4 | 41 | 51.5 | 60 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 24.4 | 28.4 | 41 | 51.5 | 60 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 24.4 | 28.4 | 41 | 51.5 | 60 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.569 | 1.33 | 1.93 | 2.44 | 2.75 |
Dividends per Share |